Incretin medicines have been very popular due to their ability to control blood sugar, weight and even heart and kidney disease risk. They work by mimicking hormones in our bodies that control appetite, blood sugar and other metabolic parameters.
Mounjaro is the latest incretin medicine. Mounjaro is approved in Singapore for the treatment of diabetes.
Mounjaro is given as a weekly self-administered subcutaneous injection. The active ingredient in Mounjaro is Tirzepatide. It mimics the actions of hormones naturally produced by the body after a meal. There are many physiological effects of Mounjaro that result in better blood sugar control, weight loss and reduction in the risk of heart and kidney disease.
The commonest side effect of Mounjaro is nausea. Other common side effects include constipation or diarrhea.
The dose of Mounajro ranges from 2.5mg to 15mg per week. Our doctors will review you regularly and adjust your dose accordingly.
Mounjaro is generally safe to be used with other medicines. If you are on other medicines to manage your diabetes, your doctor may have to adjust the doses to reduce the risk of your blood sugar dropping too low.
Mounjaro has to be kept in the fridge (between 2 and 8 degrees Celsius).
“Every patient deserves our fullest attention.”
10 Sinaran Drive #09-30, Novena Medical Centre, Singapore 307506
Tel: (+65) 6513 0359 | WhatsApp: (+65) 9750 5037
Operating Hours:
Monday to Friday: 8:30 AM to 6:30 PM
Saturday: 9:00 AM to 2:00 PM
Closed on Sundays and Public Holidays